Elutia (ELUT) Income towards Parent Company (2019 - 2026)
Elutia (ELUT) reported Income towards Parent Company of $425000.0 for Q1 2026, up 120.77% on a YoY basis from $192506.1 in Q1 2025, and down 99.45% sequentially from $77.3 million in Q4 2025.
Elutia (ELUT) Income towards Parent Company (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Income towards Parent Company data on file, last reported at $425000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company rose 120.77% year-over-year to $425000.0; the trailing twelve-month figure through Mar 2026 stood at $64.6 million (up 1209.55% YoY), and the FY2025 full-year result was $69.3 million, up 904.87% from the prior year.
- Income towards Parent Company retreated to $425000.0 in Q1 2026, from $77.3 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $77.3 million in Q4 2025 to a low of -$18.0 million in Q1 2024.
- A 5-year average of $1.7 million and a median of -$1.9 million in 2024 frame the typical range for Income towards Parent Company.
- Peak annual rise in Income towards Parent Company reached 4155.67% in 2025, while the deepest fall reached 5438.89% in 2025.
- Tracing ELUT's Income towards Parent Company over 5 years: stood at $575000.0 in 2022, then jumped by 927.48% to $5.9 million in 2023, then sank by 132.26% to -$1.9 million in 2024, then soared by 4155.67% to $77.3 million in 2025, then sank by 99.45% to $425000.0 in 2026.
- Business Quant data shows ELUT's Income towards Parent Company at $425000.0 in Q1 2026, $77.3 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 77.30 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -9.61 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | -1.91 Mn |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | 180,000.00 |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | 5.91 Mn |
| Sep 30, 2023 | -1.23 Mn |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | 1.81 Mn |
| Dec 31, 2022 | 575,000.00 |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | -9.40 Mn |
| Mar 31, 2022 | -8.15 Mn |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -8.32 Mn |
| Jun 30, 2021 | -2.39 Mn |